Stock Market Review 25AUG23 #shorts

AstraZeneca scores its second paediatric approval for Soliris in Japan – Pharmaceutical Technology

Soliris has previously been approved for use in paediatric and adult populations with paroxysmal nocturnal haemoglobinuria (PNH) and atypical haemolytic uraemic syndrome (aHUS) in the

August 25, 2023

How safe are GLP-1R agonists in early pregnancy?

JAMA Internal Medicine study examines the safety of GLP-1 receptor agonists and other second-line antidiabetic medications during early pregnancy, finding no significant increase in congenital

December 14, 2023

TDR’s Top 5 Psychedelic Developments For The Week Of October 16

Welcome to TDR’s review of the Top 5 Psychedelic Developments for the week of October 16. Aside from presenting a synopsis of events, we provide

October 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.